79.85 3.30(4.31%)09/27/2024
Haemonetics Corp. (HAE)
Haemonetics Corp. (HAE)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| HAE vs. BSX: Which Stock Is the Better Value Option? | 09/27 12:46 | zacks.com |
| Here's Why You Should Add HAE Stock in Your Portfolio Now | 09/26 09:51 | zacks.com |
| 4 Medical Product Stocks to Buy From a Prospective Industry | 09/24 09:11 | zacks.com |
| Intellia Therapeutics to Present Data from the Phase 2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the 2024 ACAAI Annual Scientific Meeting | 09/12 07:30 | globenewswire.com |
| HAE or BSX: Which Is the Better Value Stock Right Now? | 09/11 12:41 | zacks.com |
| Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024 | 09/05 06:49 | globenewswire.com |
| After Plunging -15.88% in 4 Weeks, Here's Why the Trend Might Reverse for Haemonetics (HAE) | 09/02 10:36 | zacks.com |
| Haemonetics (HAE) Set to Launch VASCADE MVP XL in US | 08/16 10:10 | zacks.com |
| Top 3 Health Care Stocks That Are Set To Fly This Quarter | 08/16 07:57 | benzinga.com |